🔹 Therapy Area

 . Severe Inflammatory Disorders

🔹Generic Name

  .  Deflazacort Tablets

🔹Composition

• Deflazacort 6 mg

• ​Excipients q.s.

🔹Dosage Form & Strength

  . Uncoated Tablet form. 6 mg. Dosage as directed by the Physician.

🔹Clinical Information

• IIndicated for Chronic arthritis, Asthma, Nephrotic syndrome, Systemic lupus erythematosus, and Duchenne muscular dystrophy.

• Used in chronic oral dosing to treat severe inflammatory disorders.

• Considered safe to start, safer to taper, and safest to continue.

🔹Pharmacological Properties

• Deflazacort is a bone-sparing corticosteroid.

• Exhibits less serious metabolic sequelae and is less diabetogenic than prednisolone.

• Suppresses the osteoblast function leading to a smaller decrease in serum osteocalcin levels.

• Has less negative impact on growth rate in children compared to other options.